tiprankstipranks
Ryman Healthcare Ltd. (DE:RH7)
FRANKFURT:RH7
Germany Market
RH7
Ryman Healthcare
RESEARCH TOOLSreports

Ryman Healthcare (RH7) Ratios

0 Followers

Ryman Healthcare Ratios

DE:RH7's free cash flow for Q4 2026 was $-0.02. For the 2026 fiscal year, DE:RH7's free cash flow was decreased by $ and operating cash flow was $-0.02. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 0.55 0.55 0.24 2.21 3.04
Quick Ratio
 0.55 0.55 0.24 2.20 2.98
Cash Ratio
 0.03 0.03 0.02 0.11 0.11
Solvency Ratio
 -0.02 -0.02 -0.05 <0.01 0.04
Operating Cash Flow Ratio
 1.01 1.01 0.46 1.76 2.12
Short-Term Operating Cash Flow Coverage
 2.14 2.14 0.00 0.00 4.62
Net Current Asset Value
$ -8.01B$ -8.01B$ -7.59B$ -7.84B$ -7.07B
Leverage Ratios
Debt-to-Assets Ratio
 0.13 0.13 0.14 0.20 0.19
Debt-to-Equity Ratio
 0.39 0.39 0.40 0.58 0.50
Debt-to-Capital Ratio
 0.28 0.28 0.28 0.37 0.33
Long-Term Debt-to-Capital Ratio
 0.26 0.26 0.28 0.37 0.32
Financial Leverage Ratio
 3.01 3.01 2.83 2.96 2.68
Debt Service Coverage Ratio
 0.21 0.12 -1.78 1.96 2.14
Interest Coverage Ratio
 -0.15 -0.15 -0.85 -1.38 -0.16
Debt to Market Cap
 0.80 0.73 0.86 0.66 0.83
Interest Debt Per Share
 1.68 1.68 2.58 3.81 4.77
Net Debt to EBITDA
 31.34 63.82 -61.78 -49.82 5.06
Profitability Margins
Gross Profit Margin
-2.22%-2.22%100.00%-0.21%-3.53%
EBIT Margin
0.99%-2.22%-10.59%-14.53%73.45%
EBITDA Margin
6.32%3.10%-3.80%-7.80%81.77%
Operating Profit Margin
-2.22%-2.22%-16.57%-10.70%-3.53%
Pretax Profit Margin
-22.24%-22.24%-30.18%-22.28%36.81%
Net Profit Margin
-21.46%-21.46%-61.20%0.73%46.03%
Continuous Operations Profit Margin
-21.46%-21.46%-61.20%0.73%46.03%
Net Income Per EBT
96.47%96.47%202.81%-3.29%125.04%
EBT Per EBIT
999.96%999.96%182.14%208.20%-1043.19%
Return on Assets (ROA)
-1.40%-1.40%-3.62%0.04%2.06%
Return on Equity (ROE)
-4.17%-4.20%-10.25%0.11%5.53%
Return on Capital Employed (ROCE)
-0.15%-0.15%-1.06%-0.55%-0.16%
Return on Invested Capital (ROIC)
-0.14%-0.14%-1.06%0.02%-0.16%
Return on Tangible Assets
-1.40%-1.40%-3.63%0.04%2.08%
Earnings Yield
-8.66%-7.96%-22.29%0.12%9.19%
Efficiency Ratios
Receivables Turnover
 4.83 4.83 5.05 0.94 0.78
Payables Turnover
 11.31 11.31 9.40 5.55 5.35
Inventory Turnover
 68.02K 68.02K 61.50K 273.21 39.67
Fixed Asset Turnover
 0.73 0.73 0.70 0.34 0.25
Asset Turnover
 0.07 0.07 0.06 0.05 0.04
Working Capital Turnover Ratio
 -9.56 -1.96 -16.52 1.34 1.17
Cash Conversion Cycle
 43.27 43.27 33.47 325.25 409.61
Days of Sales Outstanding
 75.55 75.55 72.31 389.71 468.62
Days of Inventory Outstanding
 <0.01 <0.01 <0.01 1.34 9.20
Days of Payables Outstanding
 32.29 32.29 38.84 65.79 68.21
Operating Cycle
 75.55 75.55 72.32 391.04 477.82
Cash Flow Ratios
Operating Cash Flow Per Share
 0.31 0.31 0.58 0.96 1.05
Free Cash Flow Per Share
 0.27 0.27 0.43 0.71 0.42
CapEx Per Share
 0.05 0.05 0.15 0.25 0.63
Free Cash Flow to Operating Cash Flow
 0.85 0.85 0.74 0.74 0.40
Dividend Paid and CapEx Coverage Ratio
 6.76 6.76 3.82 3.82 1.38
Capital Expenditure Coverage Ratio
 6.76 6.76 3.82 3.82 1.67
Operating Cash Flow Coverage Ratio
 0.20 0.20 0.24 0.26 0.23
Operating Cash Flow to Sales Ratio
 0.40 0.40 0.57 1.01 0.97
Free Cash Flow Yield
13.75%12.65%15.45%12.57%7.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -11.85 -12.47 -4.45 810.00 10.88
Price-to-Sales (P/S) Ratio
 2.48 2.70 2.75 5.95 5.01
Price-to-Book (P/B) Ratio
 0.49 0.53 0.46 0.88 0.60
Price-to-Free Cash Flow (P/FCF) Ratio
 7.27 7.91 6.47 7.95 12.84
Price-to-Operating Cash Flow Ratio
 6.19 6.74 4.78 5.87 5.17
Price-to-Earnings Growth (PEG) Ratio
 -0.44 0.17 <0.01 -8.21 -0.18
Price-to-Fair Value
 0.49 0.53 0.46 0.88 0.60
Enterprise Value Multiple
 70.56 150.68 -133.96 -126.06 11.18
Enterprise Value
 3.56B 3.74B 3.64B 6.40B 5.12B
EV to EBITDA
 70.56 150.68 -133.96 -126.06 11.18
EV to Sales
 4.46 4.68 5.10 9.83 9.15
EV to Free Cash Flow
 13.08 13.71 12.01 13.15 23.44
EV to Operating Cash Flow
 11.15 11.69 8.87 9.71 9.44
Tangible Book Value Per Share
 4.01 4.00 5.98 6.30 8.87
Shareholders’ Equity Per Share
 4.02 4.01 6.00 6.42 9.03
Tax and Other Ratios
Effective Tax Rate
 0.04 0.04 -1.03 1.03 -0.25
Revenue Per Share
 0.79 0.79 1.01 0.95 1.08
Net Income Per Share
 -0.17 -0.17 -0.62 <0.01 0.50
Tax Burden
 0.96 0.96 2.03 -0.03 1.25
Interest Burden
 -22.38 10.00 2.85 1.53 0.50
Research & Development to Revenue
 0.00 0.00 0.00 0.02 0.02
SG&A to Revenue
 0.00 0.00 0.76 0.64 0.32
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -1.87 -1.87 -0.80 0.00 2.11
Currency in NZD